UBS Group’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-8,284
Closed -$18.3K 8933
2023
Q2
$18.3K Sell
8,284
-1,992
-19% -$4.4K ﹤0.01% 5842
2023
Q1
$26.1K Buy
10,276
+10,140
+7,456% +$25.8K ﹤0.01% 5797
2022
Q4
$254 Sell
136
-1,044
-88% -$1.95K ﹤0.01% 9076
2022
Q3
$3K Sell
1,180
-2,116
-64% -$5.38K ﹤0.01% 8533
2022
Q2
$6K Buy
3,296
+839
+34% +$1.53K ﹤0.01% 7733
2022
Q1
$7K Sell
2,457
-13,823
-85% -$39.4K ﹤0.01% 7832
2021
Q4
$74K Buy
16,280
+13,679
+526% +$62.2K ﹤0.01% 5480
2021
Q3
$12K Buy
2,601
+616
+31% +$2.84K ﹤0.01% 6672
2021
Q2
$13K Sell
1,985
-2,544
-56% -$16.7K ﹤0.01% 6724
2021
Q1
$32K Sell
4,529
-3,009
-40% -$21.3K ﹤0.01% 5955
2020
Q4
$47K Buy
7,538
+6,069
+413% +$37.8K ﹤0.01% 5252
2020
Q3
$8K Sell
1,469
-11,658
-89% -$63.5K ﹤0.01% 6177
2020
Q2
$69K Sell
13,127
-6,127
-32% -$32.2K ﹤0.01% 4779
2020
Q1
$61K Sell
19,254
-21,537
-53% -$68.2K ﹤0.01% 4793
2019
Q4
$164K Buy
40,791
+21,088
+107% +$84.8K ﹤0.01% 4719
2019
Q3
$85K Buy
+19,703
New +$85K ﹤0.01% 4934
2019
Q2
Sell
-1,500
Closed -$8K 7213
2019
Q1
$8K Sell
1,500
-1,537
-51% -$8.2K ﹤0.01% 6126
2018
Q4
$16K Buy
+3,037
New +$16K ﹤0.01% 6038
2018
Q3
Sell
-3,500
Closed -$36K 7238
2018
Q2
$36K Buy
3,500
+1,560
+80% +$16K ﹤0.01% 5355
2018
Q1
$25K Sell
1,940
-1,145
-37% -$14.8K ﹤0.01% 5394
2017
Q4
$56K Sell
3,085
-1,586
-34% -$28.8K ﹤0.01% 4813
2017
Q3
$117K Sell
4,671
-56,855
-92% -$1.42M ﹤0.01% 4358
2017
Q2
$1.48M Buy
+61,526
New +$1.48M ﹤0.01% 2630
2017
Q1
Hold
0
6898
2016
Q4
Sell
-166
Closed -$2K 6954
2016
Q3
$2K Hold
166
﹤0.01% 6488
2016
Q2
$2K Hold
166
﹤0.01% 6533
2016
Q1
$3K Hold
166
﹤0.01% 6348
2015
Q4
$3K Sell
166
-840
-83% -$15.2K ﹤0.01% 6499
2015
Q3
$19K Sell
1,006
-860
-46% -$16.2K ﹤0.01% 5496
2015
Q2
$48K Buy
1,866
+1,015
+119% +$26.1K ﹤0.01% 4809
2015
Q1
$27K Sell
851
-616
-42% -$19.5K ﹤0.01% 5147
2014
Q4
$56K Buy
+1,467
New +$56K ﹤0.01% 4637